Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma

  1. Morante, M.
  2. Pandiella, A.
  3. Crespo, P.
  4. Herrero, A.
Revue:
Biomolecules

ISSN: 2218-273X

Année de publication: 2022

Volumen: 12

Número: 11

Type: Révision

DOI: 10.3390/BIOM12111562 GOOGLE SCHOLAR lock_openAccès ouvert editor